• A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion
• A Novel Multi-Model High Spatial Resolution Method for Analysis of DCE MRI Data: Insights from Vestibular Schwannoma Responses to Antiangiogenic Therapy in Type II Neurofibromatosis
• A rare case of schwannomatosis with meningioma: a case report
• Activation of the melanocortin-1 receptor attenuates neuronal apoptosis after traumatic brain injury by upregulating Merlin expression
• An unusual finding of an anaplastic meningioma in NF2-related schwannomatosis
• Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations
• Audiological Outcome of the Simultaneous Tumor Resection and Cochlear Implantation in Two Cases of Sporadic and Two Cases of Neurofibromatosis Type 2-Associated Intracochlear Schwannoma
• Auditory Brainstem Implant Outcomes in Tumor and Nontumor Patients: A Systematic Review
• Auditory brainstem implant: current states and future prospects
• Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis
• Bevacizumab Treatment for Patients with <em>NF2</em>-Related Schwannomatosis: A Single Center Experience
• Bilateral Inferior Rectus Schwannoma and Strabismus: A Case Report
• Bilateral intracochlear schwannomas: histopathological confirmation and outcomes following tumour removal and cochlear implantation with lateral wall electrodes
• Bilateral vestibular schwannoma with a cooccurring meningioma in a child: a case report and review of literature
• Brazilian Society of Otology task force - Vestibular Schwannoma ‒ evaluation and treatment
• Brigatinib in <em>NF2</em>-Related Schwannomatosis with Progressive Tumors
• Cancer Predisposition Syndromes in Neuro-oncology
• Case report of selumetinib as a novel therapy in a neurofibromatosis type 2-associated ependymoma
• Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis
• Clavicular window for brachial plexus schwannoma removal
• Clinical practice guideline on the management of vestibular schwannoma
• Cochlear Implantation in Neurofibromatosis Type 2-Related Schwannomatosis: Long-Term Hearing Outcomes
• Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis
• CONCENTRIC MACULAR RINGS SIGN IN COMBINED HAMARTOMA OF RETINA AND RETINAL PIGMENT EPITHELIUM
• Death in a bathtub of an adolescent with neurofibromatosis type 2 exhibiting meningioangiomatosis with white matter involvement
• Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
• Extraordinary Speech and Language Outcomes After Auditory Brainstem Implantation: Guidance From a Case Study
• Factors Affecting Speech Discrimination After Vestibular Schwannoma Resection
• Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis
• Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance
• G6PD and ACSL3 are synthetic lethal partners of NF2 in Schwann cells
• Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions
• Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials
• Generation of a zebrafish neurofibromatosis model via inducible knockout of <em>nf2</em>
• Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study
• Hearing Function after CyberKnife for Vestibular Schwannoma: A Systematic Review
• Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis
• Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools
• Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
• Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis
• Incidence of tethered cord syndrome in neurofibromatosis types 1 and 2 pediatric patients: a population-level analysis
• Intraoperative assessment of cochlear nerve functionality in various vestibular schwannoma scenarios: Lessons learned
• Is vestibular schwannoma really a benign tumor? Case report and review
• Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
• Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective
• Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2
• Low back pain with axillary mass in a perimenopausal woman: A case of schwannomatosis mimicking metastasis
• Malignant perineurioma derived from the retroperitoneum with an aggressive clinical course: a case report
• Malignant Transformation of Benign Meningiomas with or without Radiotherapy
• Management of Bevacizumab-Induced Proteinuria Using an Angiotensin Receptor Blocker (ARB) in a Neurofibromatosis Type 2 (NF-2) Patient With Vestibular Schwannoma
• Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis
• Meningioma
• Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates
• Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration
• Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells
• Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution
• MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas
• Natural history of hearing and tumor growth in vestibular schwannoma in neurofibromatosis type 2-related schwannomatosis
• Navigating Uncharted Waters: Comparative Analysis of Clinical Progression and Outcomes in Vestibular Schwannoma Patients with Papilledema and without Hydrocephalus, Versus Those without Papilledema and Hydrocephalus: A Comprehensive Institutional Insight
• Neurocutaneous Disorders in Pregnancy
• Neurofibromatosis
• Neurofibromatosis Type 1
• Neurofibromatosis type 1: Clinical characteristics and mutation spectrum in a North Indian cohort
• Neurofibromatosis type 2 in the otorhinolaryngological practice
• New classification and approaches to the treatment of schwannomatosis
• NF2-Related Schwannomatosis (NF2): Molecular Insights and Therapeutic Avenues
• NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
• Patient Characteristics Impacting Adherence to Serial Observation for Vestibular Schwannomas
• Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials
• PD-L1 regulates tumor proliferation and T-cell function in NF2-associated meningiomas
• Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature
• Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
• Phase I/II Study of a Vascular Endothelial Growth Factor Receptor Vaccine in Patients With NF2-Related Schwannomatosis
• Predictors of clinical and structural outcomes after surgery for spinal nerve sheath tumor resection: a retrospective analysis
• Radiation-Induced Sensorineural Hearing Loss and Potential Management
• Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials
• Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study
• Retinal Ischemia as a Presenting Ocular Sign of Neurofibromatosis Type 2
• Schwannoma, Neurofibromatosis Type 2, and Schwannomatosis in the 2021 WHO Classification of Tumors of the Central Nervous System
• Schwannomatosis: a Realm Reborn: year one
• Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis
• Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis
• Spatial Landscape of Malignant Pleural and Peritoneal Mesothelioma Tumor Immune Microenvironments
• Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2
• Sporadic pediatric vestibular schwannoma: a case report in a 4-year-old boy
• Sporadic vestibular schwannoma in a pediatric population: a case series
• Squamous Metaplasia in a Schwannoma: A Unique Histologic Finding
• Surgical management of sporadic and schwannomatosis-associated pelvic schwannomas
• Susceptibility-Weighted MRI for Predicting NF-2 Mutations and S100 Protein Expression in Meningiomas
• Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma
• The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling
• The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis
• The molecular biology of NF2/Merlin on tumorigenesis and development
• TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular Carcinoma
• Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas
• Unilateral Multifocal Inner Ear and Internal Auditory Canal or Cerebellopontine Angle Cochleovestibular Schwannomas-Genetic Analysis and Management by Surgical Resection and Cochlear Implantation
• Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
• Vestibular Schwannoma
• Vestibular schwannoma unveiled by pregnancy: A case report and literature review
• Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients